CollPlant Biotechnologies Ltd Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
CollPlant Biotechnologies Ltd (CLGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $1.03 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-26
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|
| 2025-12-31 | $1.03M 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $1.18M 6-K · filed 2025-08-20 | ||
| 2024-12-31 | $1.55M 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $555.00K 6-K · filed 2025-08-20 | $1.18M 6-K · filed 2024-08-20 | |
| 2023-12-31 | $4.38M 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $1.71M 6-K · filed 2024-08-20 | ||
| 2022-12-31 | $2.80M 20-F · filed 2025-03-26 | ||
| 2021-12-31 | $3.36M 20-F · filed 2024-04-04 | ||
| 2020-12-31 | $1.94M 20-F · filed 2023-03-29 |